Close Menu

NEW YORK – The National Institutes of Health said Wednesday that it is awarding more than $129.3 million in contracts to nine diagnostic firms under its Rapid Acceleration of Diagnostics (RADx) initiative to expand testing and manufacturing capacity and support development of new rapid SARS-CoV-2 tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.